Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 526-535

  De Angelis, P ^a   Clausen, O P F ^a   Schjolberg A ^a   Stokke, T ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colorectal tumours; Direct CGH; Gains; Losses; Oncogenes; Tumour suppressor genes

Indexed keywords

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CHROMOSOME 18Q; CHROMOSOME 20Q; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLOW CYTOMETRY; GENE MAPPING; GENE MUTATION; GENOTYPE; HUMAN; MALE; METAPHASE CHROMOSOME; ONCOGENE; PHENOTYPE; PLOIDY; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR SUPPRESSOR GENE;

EID: 0032903791     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690388     Document Type: Article

References (56)

1. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mechklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B and de la Chapelle A (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816
2. Andersen SN, Lovig T, Breivik J, Lund E, Gaudernack G, Meling GI and Rognum TO (1997) K-ras mutations and prognosis in large-bowel carcinomas. Scand J Gastroenterol 32: 62-69
3. Arnold N, Hagele L, Walz L, Schempp W, Pfisterer J, Bauknecht T, and Kiechle M (1996) Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16: 46-54
4. Bardi G, Sukhikh T, Pandis N, Fenger C, Kronborg O and Heim S (1995) Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer 12: 97-109
5. Bauer KD, Bagwell CB, Giaretti W, Melamed M, Zarbo RD, Witzig TE and Rabinovitch P (1993) Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14: 486-491
6. Bigner SH, Bjerkvig R, Læarum OD, Muhlbaier LH and Bigner DD (1987) DNA content and chromosomes in permanent cultured cell lines derived from malignant human gliomas. Anal Quant Cytol Histol 9: 435-444
7. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scrambler P, Sheer D, Solomon E and Spurr NK (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614-616
8. Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689
9. Campo E, de la Calle-Martin O, Miquel R, Palacin A, Romero M, Fabregat V, Vives J, Cardesa A and Yague J (1991) Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 51: 4436-4442
10. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB and Jensen RH (1994) Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer 11: 153-162
11. Cusick, EL, Milton JI and Ewen SWB (1990) The resolution of aneuploid DNA stem lines by flow cytometry: limitations imposed by the coefficient of variation and the percentage of aneuploid nuclei. Anal Cell Pathol 2: 139-148
12. De Angelis P, Stokke T, Smedshammer L, Lothe RA, Meling GI, Rofstad M, Chen Y and Clausen OPF (1993) p53 expression is associated with a high degree of tumor DNA aneuploidy and incidence of p53 gene mutation, and is localized to the aneuploid component in colorectal carcinomas. Int J Oncol 3: 305-312
13. De Angelis P, Stokke T, Smedshammer L, Lothe RA, Lehne G, Chen Y and Clausen OPF (1995) P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo. Br J Cancer 72: 307-311
14. De Angelis PM, Stokke T and Clausen OPF (1997) NO38 expression and nucleolar counts are correlated with cellular DNA content but not with proliferation parameters in colorectal carcinomas. J Clin Pathol Mol Pathol 50: 201-208
15. De Angelis PM, Stokke T, Thorstensen L, Lothe RA and Clausen OPF (1998) Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and associations with p53 genotype/phenotype. J Clin Pathol Mol Pathol 51: 254-261
16. Delattre O, Law DJ, Remvikos Y, Sastre X, Feinberg AP, Olschwang S, Melot T. Salmon RJ, Validire P and Thomas G (1989) Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 2: 353-356
17. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL and Attisano L (1996) MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552
18. Fearon ER, Hamilton SR and Vogelstein B (1987) Clonal analysis of human colorectal tumors. Science 238: 193-196
19. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
20. Giaretti W (1993) A model on the origin and evolution of DNA aneuploidy. Int J Oncol 2: 165-171
21. Giaretti W, Monaco R, Pujic N, Rapallo A, Nigro S and Geido E (1996) Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas. Association with degree of DNA aneuploidy. Am J Pathol 149: 1-9
22. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353
23. Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, Shah K, Auer G and Ried T (1997) Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 19: 233-240
24. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF and Sandberg AA (1984) Convention on nomenclature for DNA cytometry. Cytometry 5: 445-446
25. Houlston RS and Tomlinson IPM (1997) Genetic prognostic markers in colorectal cancer. J Clin Pathol Mol Pathol 50: 281-288
26. Hyas M and Tomlinson IPM (1996) Genetic pathways in colorectal cancer. Histopathology 28: 389-399
27. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
28. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G. DeVries S, Kerschmann R, Caroll P, and Waldman F (1995) Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hyhridization. Genes Chromosomes Cancer 12: 213-219
29. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman F, Gray JW and Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243
30. Karhu R, Kahkonen M, Kuukasjarvi T, Pennanen S, Tirkkonen M and Kallioniemi O (1997) Quality control of CGH: impact of metaphase chromosomes and the dynamic range of hybridization. Cytometry 28: 198-205
31. Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, Iino H, Fukayama M, Koike M, Mori T, Sakuraba H, Fukunari H, Iwama T and Miyaki M (1992) Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 52: 3965-3971
32. Korn WM, Oide Weghuis DE, Suijkerbuijk RF, Schmidt U, Otto T, du Manoir S, Geurts van Kessel A, Harstrick A, Seeber S and Becher R (1996) Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridization. Genes Chromosomes Cancer 17: 78-87
33. Lothe RA, Peltomaki P, Meling GJ, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Møller P, Rognum TO, Fosså SD, Haldorsen T, Langmark F, Brøgger A, de la Chapelle A and Børresen A-L (1993) Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history. Cancer Res 53: 5849-5852
34. MacGrogan D, Pegram M, Slamon D and Bookstein R (1997) Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15: 1111-1114
35. Meling GI, Lothe RA, Børresen A-L, Graue C, Hange S, Clausen OPF and Rognum TO (1993) The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables. Br J Cancer 67: 93-98
36. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K, Muraoka M, Takahashi H, Amada Y, Fukuyama M, Maeda Y, Iwama T, Mishima Y, Mori T and Koike M (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54: 3011-3020
37. Miyashita T and Reed J (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
38. Muleris M, Salmon RJ and Dutrillaux B (1990) Cytogenetics of colorectal adenocarcinomas. Cancer Genet Cytogenet 46: 143-156
39. Nakao K, Shibusawa M, Tsunoda A, Yoshizawa H, Murakami M, Kusano M, Uesugi N and Sasaki K (1998) Genetic changes in primary colorectal cancer by comparative genomic hybridization. Surg Today 28: 567-569
40. Offerbaus A, Johan G, Defeyter EP, Cornelisse CJ, Tersmette KW, Floyd J, Kern SE, Vogelstein B and Hamilton SR (1992) The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 102: 1612-1619
41. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thihodeau SN, Vogelstein B and Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237
42. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC and Perucho M (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969
43. Remvikos Y, Laurent-Puig P, Salmon RJ, Frelat G, Dutrillaux B and Thomas G (1990) Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer 45: 450-456
44. Remvikos Y, Vogt N, Muleris M, Salmon RJ, Malfoy B and Dutrillaux B (1995) DNA-repeat instability is associated with colorectal cancer presenting minimal chromosomal rearrangements. Genes Chromosomes Cancer 12: 272-276
45. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S and Auer G (1996) Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15: 234-245
46. Rognum TO, Lund E, Meling GI and Langmark F (1991) Near diploid large bowel carcinomas have better five-year survival than aneuploid ones. Cancer 68: 1077-1081
47. Shackney SE and Shankey TV (1997) Common patterns of genetic evolution in human solid tumors. Cytometry 29: 1-27
48. Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, Ketterer DM, and Pollice AA (1989) Model for the genetic evolution of human solid tumors. Cancer Res 49: 3344-3354
49. Solomon E, Voss R, Hall V, Bodmer WF, Jass JR. Jeffreys AJ, Lucibello FC, Patel I and Rider SH (1987) Chromosome 5 allele loss in human colorectal carcinomas. Nature 328: 616-619
50. Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K and Saji S (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111: 1369-1372
51. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo, W-L, Waldman FM, Isola JJ, Gray JW and Kallioniemi O-P (1994) Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 54: 4257-4260
52. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW and Vogelstein B (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13: 343-346
53. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J and Kallioniemi O-P (1998) Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21: 177-184
54. Tribukait B, Granberg-Ohman I and Wijkstrom H (1986) Flow cytometric DNA and cytogenetic studies in human tumors: a comparison and discussion of the differences in modal values obtained by the two methods. Cytometry 7: 194-199
55. Vindeløv LL, Christensen IJ and Nissen NI (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327
56. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM and Bos JL (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319: 525-532